Previous reports apparently showed that the effect of antidiabetic drug such as sodium-glucose cotransporter 2 inhibitors (SGLT2i) on renal function and NAFLD. The gene discussed is SLC5A2; the disease is metabolic dysfunction-associated steatotic liver disease.